Edge Financial Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by Edge Financial Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Edge Financial Advisors from 13F filings

Historical chart of Edge Financial Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Edge Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Edge Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $248k 2.7k 90.70

More positions owned by Edge Financial Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Vanguard Index Fds Growth Etf (VUG)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Goldman Sachs Etf Tr Activebeta Eme (GEM)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Netflix (NFLX)
Ishares Tr Msci Eafe Etf (EFA)
Amazon (AMZN)
J P Morgan Exchange Traded F Div Rtn Em Eqt (JPEM)
Accenture Plc Ireland Shs Class A (ACN)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
JPMorgan Chase & Co. (JPM)

View all positions for Edge Financial Advisors

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Jpmorgan Chase & Co
Miller Investment Management
Prime Capital Investment Advisors
Independent Advisor Alliance
Phoenix Holdings
Citadel Advisors
Avestar Capital
Gladstone Institutional Advisory
Hrt Financial
Twelve Points Wealth Management
Bank Hapoalim Bm

View all funds holding Vaneck Vectors Pharmaceutical etf